user

Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)

被引：0
|
作者：
Laack, E. [1 ]
Reck, M. [2 ]
Schumann, C. [3 ]
Eschbach, C. [4 ]
Kimmich, M. [5 ]
Brandts, C. [6 ]
Paz-Ares, L. G. [7 ]
De Marinis, F. [8 ]
Dediu, M. [9 ]
Pujol, J.-L. [10 ]
Bidoli, P. [11 ]
Molinier, O. [12 ]
Sahoo, T. P. [13 ]
Corral, J. [14 ]
Melemed, S. A. [14 ]
John, W. J. [14 ]
Chouaki, N. [15 ]
Zimmermann, A. H. [14 ]
Visseren-Grul, C. M. [16 ]
Leschinger, M., I [17 ]
Thomas, M. [18 ]
机构：
[1] Ambulantes Krebszentrum, Hamburg, Germany
[2] Krankenhaus Grosshansdorf, Grosshansdorf, Germany
[3] Univ Ulm Klinikum, Sekt Pneumol, Ulm, Germany
[4] Asklepios Klin Hamburg, Hamburg, Germany
[5] Klin Schillerhohe, Gerlingen, Germany
[6] Uniklin, Frankfurt, Germany
[7] Hosp Univ Virgen del Rocio, Seville, Spain
[8] San Camillo Forlanini Hosp, Rome, Italy
[9] Inst Oncol Bucharest, Bucharest, Romania
[10] Montpellier Univ Hosp, Montpellier, France
[11] Az Osped S Gerardo, Monza, Italy
[12] Les Mans Reg Hosp, Le Mans, France
[13] Jawaharlal Nehru Canc Hosp & Res Ctr, Bhopal, India
[14] Eli Lilly & Co, Indianapolis, IN 46285 USA
[15] Lilly France, Suresnes, France
[16] Lilly Oncol Europe, Houten, Netherlands
[17] Lilly Deutschland GmbH, Med, Oncol, Bad Homburg, Germany
[18] Univ Heidelberg, Thoraxklin, Heidelberg, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [21] First-line chemotherapy (CT) with pemetrexed (PEM) plus cisplatin (CIS) plus bevacuzimab (BEV) followed by maintenance PEM plus BEV for advanced nonsquamous non-small cell lung cancer (NS-NSCLC): Final results of a single-arm phase II study.
    Hillerdal, Gunnar N.
    Sorensen, Jens Benn
    Hoeffken, Gert
    Favaretto, Adolfo
    Perez-Carrion, Ramon
    Visseren-Grul, Carla
    Ameryckx, Sophie
    Soldatenkova, Victoria
    Bourayou, Nawel
    Santoro, Armando
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Vinorelbine(VNR) plus best supportive care (BSC) vs BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (pts). Results of a phase III randomized trial
    Gridelli, C
    Ianniello, GP
    Maiorino, L
    Piantedosi, V
    Cigolari, S
    Manzione, L
    Failla, G
    Zuccarino, L
    Pedicini, T
    Vinante, O
    Castiglione, F
    Clerici, M
    Bearz, A
    Darwish, S
    Rossi, A
    Monfardini, S
    Gallo, C
    Perrone, F
    Frontini, L
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [23] Vinorelbine (VNR) plus best supportive care (BSC) vs BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (Pts). Results of a phase III randomized trial
    Gridelli, C
    Ianniello, GP
    Maiorino, L
    Brancaccio, L
    Cigolari, S
    Bilancia, D
    Aiello, R
    Zuccarino, L
    Pedicini, T
    Zonato, S
    Pappagallo, GL
    Monfardini, S
    Rossi, A
    Gallo, C
    Perrone, F
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 3 - 3
  • [24] AERIO News in brief Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
    Cochereau, D.
    Tredaniel, J.
    [J]. ONCOLOGIE, 2013, 15 (01) : 61 - 62
  • [25] Vinorelbine plus best supportive care (BSC) vs BSC in the treatment of advanced non small cell lung cancer (NSCLC) elderly patients (pts). Results of a phase III randomized trial
    Clerici, M
    Frontini, L
    Ianniello, GP
    Maiorino, L
    Piantedosi, FV
    Cigolari, S
    Manzione, L
    Failla, G
    Zuccarino, L
    Pedicini, T
    Vinante, O
    Castiglione, F
    Bearz, A
    Tonato, M
    Rossi, A
    Monfardini, S
    Gallo, C
    Perrone, F
    Gridelli, C
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 62 - 62
  • [26] Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Gridelli, Cesare
    de Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Middleton, Gary
    Corral, Jesus
    Winfree, Katherine
    Melemed, Symantha
    Zimmermann, Anna
    John, William
    Beyrer, Julie
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz-Ares, Luis G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : 1713 - 1721
  • [27] Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy
    Thongprasert, S
    Sanguanmitra, P
    Juthapan, W
    Clinch, J
    [J]. LUNG CANCER, 1999, 24 (01) : 17 - 24
  • [28] Pemetrexed (Pem) Maintenance Therapy in Elderly Patients (Pts) With Good Performance Status (PS) - Analysis of PARAMOUNT Phase III Study of Pem Versus Placebo in Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC)
    Gridelli, C.
    Thomas, M.
    Prabhash, K.
    El Kouri, C.
    Blackhall, F.
    Melemed, S.
    Zimmermann, A.
    Chouaki, N.
    Visseren-Grul, C.
    Paz-Ares, L. G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S613 - S613
  • [29] A phase III study of pemetrexed (Pem) plus carboplatin (Cb) plus bevacizumab (Bev) followed by maintenance pem plus bev versus paclitaxel (Pac) plus cb plus bev followed by maintenance bev in stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC): Overall and age group results.
    Socinski, Mark A.
    Patel, Jyoti D.
    Garon, Edward B.
    Govindan, Ramaswamy
    Reynolds, Craig H.
    Spigel, David R.
    Olsen, Mark R.
    Liu, Jingyi
    Guba, Susan C.
    Bonomi, Philip
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
    Ciuleanu, Tudor
    Brodowicz, Thomas
    Zielinski, Christoph
    Kim, Joo Hang
    Krzakowski, Maciej
    Laack, Eckart
    Wu, Yi-Long
    Bover, Isabel
    Begbie, Stephen
    Tzekova, Valentina
    Cucevic, Branka
    Pereira, Jose Rodrigues
    Yang, Sung Hyun
    Madhavan, Jayaprakash
    Sugarman, Katherine P.
    Peterson, Patrick
    John, William J.
    Krejcy, Kurt
    Belani, Chandra P.
    [J]. LANCET, 2009, 374 (9699): : 1432 - 1440
12345